ProShares Ultra Nasdaq Biotechnology Rating

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)

$57.66

+0.61 (+1.07%)

(As of 12:27 PM ET)

ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

BIB Aggregate Rating

Moderate Buy

2.56

Holdings in BIB have an aggregate rating of Moderate Buy based on 561 analyst ratings issued in the past year covering 43 companies (54.2% of the portfolio).

BIB Aggregate Price Target

$67.05
16.28% Upside

High Prediction	$88.04
Average Prediction	$67.05
Low Prediction	$48.37

Holdings in BIB have an aggregate price target of $67.05 and a range of $48.37 to $88.04 covering 43 companies (54.2% of the portfolio).

BIB Consensus Ratings of Holdings

Strong Buy	0 Strong Buy rating(s)
Buy	6 Buy rating(s)
Moderate Buy	26 Moderate Buy rating(s)
Hold	10 Hold rating(s)
Reduce	0 Reduce rating(s)
Sell	1 Sell rating(s)
Strong Sell	0 Strong Sell rating(s)

Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology

Strong Sell

Sell

Reduce

Hold

Moderate Buy

Buy

Strong Buy

Ratings for the Top 43 BIB Holdings

Export to Excel

Weight In ETF	Company	Share Price	MarketRank™	Consensus Rating Score	Consensus Price Target	Possible Upside	Number of Ratings	Indicator(s)
6.47%	AMGN Amgen	$313.83 +0.4%	5 of 5 stars	2.52	$305.65	-2.6%	21
5.64%	REGN Regeneron Pharmaceuticals	$980.73 -0.2%	4 of 5 stars	2.76	$989.36	0.9%	21	Insider Selling
5.42%	VRTX Vertex Pharmaceuticals	$446.31 +0.2%	4 of 5 stars	2.48	$432.18	-3.2%	25	Analyst Upgrade Positive News
5.11%	GILD Gilead Sciences	$67.70 0.0%	5 of 5 stars	2.35	$83.69	23.6%	17
3.47%	MRNA Moderna	$140.34 +5.6%	4 of 5 stars	2.24	$126.46	-9.9%	17	Insider Selling
3.23%	AZN AstraZeneca	$77.04 +0.2%	2 of 5 stars	2.57	$81.00	5.1%	7
2.30%	BIIB Biogen	$231.16 +0.3%	5 of 5 stars	2.65	$288.46	24.8%	26	Positive News
1.39%	ALNY Alnylam Pharmaceuticals	$149.07 -0.2%	5 of 5 stars	2.59	$216.19	45.0%	17	Short Interest ↑
1.36%	ILMN Illumina	$109.72 -1.2%	5 of 5 stars	2.30	$164.65	50.1%	20	Gap Up
1.13%	BMRN BioMarin Pharmaceutical	$76.46 -1.4%	5 of 5 stars	2.57	$106.11	38.8%	21	Analyst Downgrade
1.02%	VTRS Viatris	$11.10 +1.1%	1 of 5 stars	1.33	$11.00	-0.9%	3
1.02%	NBIX Neurocrine Biosciences	$140.35 -1.4%	5 of 5 stars	2.79	$148.96	6.1%	24
0.97%	SNY Sanofi	$48.55 -0.2%	3 of 5 stars	2.40	$55.00	13.3%	5	Analyst Revision
0.92%	RPRX Royalty Pharma	$27.50 +0.8%	5 of 5 stars	3.00	$46.75	70.0%	4	Positive News
0.91%	SRPT Sarepta Therapeutics	$129.18 -1.7%	4 of 5 stars	2.86	$163.94	26.9%	14	Analyst Forecast
0.90%	UTHR United Therapeutics	$273.12 -0.4%	5 of 5 stars	2.90	$308.78	13.1%	10
0.88%	ARGX argenx	$366.42 +0.2%	3 of 5 stars	2.71	$524.68	43.2%	21	Earnings Report
0.88%	INCY Incyte	$57.19 +0.2%	5 of 5 stars	2.47	$74.93	31.0%	17
0.88%	MEDP Medpace	$400.28 +1.8%	5 of 5 stars	2.80	$443.00	10.7%	5
0.67%	ROIV Roivant Sciences	$11.31 +0.7%	2 of 5 stars	2.90	$16.90	49.4%	10	Positive News
0.65%	BNTX BioNTech	$91.54 +1.0%	1 of 5 stars	2.20	$111.70	22.0%	10	Positive News
0.57%	ASND Ascendis Pharma A/S	$120.88 -0.2%	1 of 5 stars	2.88	$176.88	46.3%	8
0.52%	PCVX Vaxcyte	$75.53 +1.3%	0 of 5 stars	3.00	$78.50	3.9%	4
0.50%	JAZZ Jazz Pharmaceuticals	$108.08 -0.8%	5 of 5 stars	2.85	$192.75	78.3%	13
0.49%	BGNE BeiGene	$172.65 -0.1%	3 of 5 stars	2.80	$251.93	45.9%	10	Positive News
0.49%	CYTK Cytokinetics	$60.47 +1.6%	4 of 5 stars	2.87	$81.60	34.9%	15
0.48%	RVMD Revolution Medicines	$39.89 +1.2%	4 of 5 stars	3.10	$43.20	8.3%	10
0.48%	EXEL Exelixis	$21.08 +0.8%	5 of 5 stars	2.59	$26.13	23.9%	17
0.48%	ITCI Intra-Cellular Therapies	$65.35 +0.5%	5 of 5 stars	2.90	$90.17	38.0%	10	Positive News
0.48%	BPMC Blueprint Medicines	$104.74 -0.2%	1 of 5 stars	2.53	$102.65	-2.0%	17
0.44%	IONS Ionis Pharmaceuticals	$37.80 +1.3%	5 of 5 stars	2.71	$59.54	57.5%	14	Gap Down
0.44%	IBRX ImmunityBio	$7.01 -8.4%	0 of 5 stars	2.00	$6.00	-14.4%	1	Gap Up
0.42%	APLS Apellis Pharmaceuticals	$42.33 +2.5%	5 of 5 stars	2.87	$76.67	81.1%	15	Analyst Revision Positive News
0.37%	HALO Halozyme Therapeutics	$44.51 -0.4%	5 of 5 stars	2.83	$53.14	19.4%	6	Positive News
0.36%	BBIO BridgeBio Pharma	$29.70 -1.3%	5 of 5 stars	2.91	$48.00	61.6%	11	Analyst Forecast
0.33%	MDGL Madrigal Pharmaceuticals	$229.08 +4.1%	4 of 5 stars	2.73	$345.09	50.6%	11	Gap Down
0.33%	KRYS Krystal Biotech	$164.04 0.0%	5 of 5 stars	3.00	$171.00	4.2%	9	Short Interest ↑
0.33%	CRSP CRISPR Therapeutics	$55.70 -0.9%	3 of 5 stars	2.35	$73.93	32.7%	17	Gap Up
0.31%	ALPN Alpine Immune Sciences	$64.97 +0.0%	2 of 5 stars	2.27	$52.33	-19.5%	11	Positive News High Trading Volume
0.30%	NUVL Nuvalent	$71.03 +0.2%	3 of 5 stars	2.90	$90.78	27.8%	10	Analyst Forecast
0.30%	IMVT Immunovant	$30.64 -0.2%	2 of 5 stars	3.00	$48.00	56.7%	17	Upcoming Earnings Short Interest ↑
0.29%	ALKS Alkermes	$24.40 +1.0%	5 of 5 stars	2.50	$35.38	45.0%	10	Positive News
0.28%	IOVA Iovance Biotherapeutics	$10.35 +1.1%	5 of 5 stars	3.00	$24.64	138.0%	10

This page (NASDAQ:BIB) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

ProShares Ultra Nasdaq Biotechnology Rating

ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2024)

BIB Aggregate Rating

BIB Aggregate Price Target

BIB Consensus Ratings of Holdings

Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology

Ratings for the Top 43 BIB Holdings

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info